PRESS RELEASE FOR WEBSITE
March 14th 2018
The BioCube Corporation is pleased to announce that an agreement has been signed with Leenlife Pharma International Inc. This was preceded by the purchase of a BioCube 250 by Leenlife Corporation.
Based in Vancouver B.C. LeanLife Health produces and distributes specialised Omega 3 formulations which can be used as high quality food additives or as a nutraceutical. LeanLife products have been used in making bread, noodles, cheese and milk products. Their industry leading Omega 3 product formulations have no cholesterol and high purity, with no toxic substances. They are offered as an oil, emulsion and powder.
The agreement was sealed after extensive research and discussions between the two companies dating back to mid 2017. It includes an exclusive arrangement with BioCube Corporation Ltd to purchase equipment to manufacture LeanLife Health’s Omega 3 products. It encompasses production of a specialised BioCube technology with minimum purchase and timing thresholds.
BioCube has developed a proprietary processing plant, having intellectual property including patents, patent applications and proprietary information and technical information (the “BioCube Processor”). Leenlife Pharma International has identified a use for the BioCube Processor, along with proprietary technology of its own, to process its Omega 3 products and it has been agreed with BioCube that it manufacture a BioCube Processor exclusively for the Company.
LeanLife Health CEO Stan Lis said:
“BioCube, offers LeanLife Health an on or off-grid platform that provides seamless integration into the commercial production process of LeanLife’s proprietary and industry leading Omega-3 formulations. We are totally satisfied that the efficiency of the BioCube and the BioCube process will address concerns of food grade quality control, cost, production quotas and handling. The Company is planning to set up operations in the Vancouver area to produce and market its products in North America.”.
The global Omega 3 market was valued at 10 billion USD in 2016 and is expected to reach 16 billion USD by the end of 2023, growing at a CAGR of 7.57% between 2016 and 2023.
BioCube Corporation CEO, David Tait said:
“This is an exciting new business arena for BioCube Corporation. Diversifying our business into the food additives sector opens up a whole new world of opportunity with the potential to increase demand for our technology and add value for our shareholders. Our proprietary technology has proven its capability to process renewable feedstocks into highest quality end products and it will do so in this product sector for LeanLife Health Inc. We look forward to developing our relationship and business with LeanLife.”
About The BioCube Corporation
The BioCube Corporation Ltd is an unlisted public company. The company designed, developed and manufactures the BioCube™; a compact, transportable and affordable community-sized biodiesel processor. The BioCube™ can process high quality biodiesel from a wide variety of feedstock that can be used directly in any modern diesel engines without modification. The BioCube fuels energy independence by making sustainable distributed biodiesel processing viable for commercial and community enterprises around the world. The company has operations in Queensland Australia, and Vancouver, BC Canada (for further information contact email@example.com)
About LeanLife Health Inc.
LeanLife Health Inc. is based in Vancouver, B.C. Canada and is engaged in the business of manufacturing and distributing high quality Omega 3 formulations which can be used as food additives and nutraceuticals.
For more information, please contact:
Stan Lis, CEO
Tel: 604 764-0518